News
HSIC
69.82
+1.26%
0.87
Weekly Report: what happened at HSIC last week (1216-1220)?
Weekly Report · 8h ago
Should You Retain Henry Schein Stock in Your Portfolio Right Now?
NASDAQ · 4d ago
How Is The Market Feeling About Henry Schein?
Benzinga · 6d ago
Henry Schein to Participate at J.P. Morgan’s Healthcare Investor Conference
Barchart · 6d ago
Henry Schein, Inc.'s (NASDAQ:HSIC) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Simply Wall St · 12/16 15:21
Weekly Report: what happened at HSIC last week (1209-1213)?
Weekly Report · 12/16 09:16
Analysts Offer Insights on Healthcare Companies: Evolus (EOLS), Ultragenyx Pharmaceutical (RARE) and Henry Schein (HSIC)
TipRanks · 12/16 06:40
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
Benzinga · 12/12 19:32
Lantheus Holdings: A Growing Business With Dominant Market Share
Seeking Alpha · 12/12 19:01
Early notable gainers among liquid option names on December 11th
TipRanks · 12/11 14:55
Henry Schein: The Kind Of Business I Like But No Margin Of Safety Now
Seeking Alpha · 12/10 19:52
Analysts Offer Insights on Healthcare Companies: Tectonic Therapeutic (TECX), Henry Schein (HSIC) and Geron (GERN)
TipRanks · 12/10 06:11
Weekly Report: what happened at HSIC last week (1202-1206)?
Weekly Report · 12/09 09:15
Thursday Sector Laggards: Technology & Communications, Healthcare
NASDAQ · 12/05 19:36
GE Vernova initiated, Merck upgraded: Wall Street’s top analyst calls
TipRanks · 12/04 14:41
The Analyst Verdict: Henry Schein In The Eyes Of 4 Experts
Benzinga · 12/04 13:00
HENRY SCHEIN INC <HSIC.O>: MIZUHO INITIATES COVERAGE WITH NEUTRAL RATING; PRICE TARGET $75
Reuters · 12/04 12:13
U.S. RESEARCH ROUNDUP-Alignment Healthcare, Hanmi Financial, Honeywell
Reuters · 12/04 07:45
Henry Schein initiated with a Neutral at Mizuho
TipRanks · 12/03 21:30
Stocks with improving and deteriorating ‘TechniGrade’ by Piper Sandler
Seeking Alpha · 12/03 18:52
More
Webull provides a variety of real-time HSIC stock news. You can receive the latest news about Henry Schein through multiple platforms. This information may help you make smarter investment decisions.
About HSIC
Henry Schein, Inc. is a solutions company for health care professionals powered by a network of people and technology. The Company operates through two segments: health care distribution, and technology and value-added services. The health care distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, dental specialty products (including implant, orthodontic and endodontic products), diagnostic tests, infection-control products, personal protective equipment products and vitamins. The technology and value-added services segment provide software, technology and other value-added services to health care practitioners. It offers dental practice management solutions for dental and medical practitioners. It also develops solutions for the orthopedic treatment of lower extremities (foot and ankle) and upper extremities (primarily hand and wrist).